Newsroom

Salt Lake City – August 28, 2025 – Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to…

Sera announced financial results for the second quarter of 2025 ended June 30, 2025.

Sera today announced that it will report second quarter fiscal year 2025 financial results on Wednesday, August 6, 2025, after the close of the market.

Sera announced that members of the Sera team will participate in upcoming investor conferences.

Sera announced that the company will present at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, from 9:30 – 9:55 a.m. ET.

Sera announced the appointment of Lee Anderson as Chief Commercial Officer.

Sera announced financial results for the first quarter of 2025 ended March 31, 2025.

Sera announced that it will report first quarter fiscal year 2025 financial results on Wednesday, May 7, 2025, after the close of the market.

Sera announced that Jeff Elliott will join its Board of Directors on March 20, 2025.

Sera announced financial results for the fourth quarter and full year ended December 31, 2024.